|4Feb 12, 4:22 PM ET

Martell Bridget A 4

4 · Kura Oncology, Inc. · Filed Feb 12, 2020

Insider Transaction Report

Form 4
Period: 2020-02-10
Martell Bridget A
Acting Chief Medical Officer
Transactions
  • Award

    Option to purchase common stock

    2020-02-10+50,00050,000 total
    Exercise: $12.22Exp: 2030-02-09Common Stock (50,000 underlying)
  • Award

    Option to purchase common stock

    2020-02-10+50,00050,000 total
    Exercise: $12.22Exp: 2030-02-09Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]This option vests in full on the one year anniversary of the date of grant.
  • [F2]1/4th of the shares vest on the one year anniversary of the date of grant, and 1/48th of the shares vest in 36 monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION